FOXM1 variant contributes to gefitinib resistance via activating wnt/β-catenin signal pathway in non-small cell lung cancer patients
Ontology highlight
ABSTRACT: FOXM1 variant contributes to gefitinib resistance via activating wnt/β-catenin signal pathway in non-small cell lung cancer patients
PROVIDER: PRJNA828031 | ENA |
REPOSITORIES: ENA
ACCESS DATA